Literature DB >> 100492

Carbohydrate on human factor VIII/von Willebrand factor. Impairment of function by removal of specific galactose residues.

J M Sodetz, J C Paulson, S V Pizzo, P A McKee.   

Abstract

Human factor VIII/von Willebrand factor protein containing 120 +/- 12 nmol of sialic acid and 135 +/- 13 nmol of galactose/mg of protein was digested with neuraminidase. The affinity of native factor VIII/von Willebrand factor and its asialo form for the hepatic lectin that specifically binds asialoglycoproteins was assessed from in vitro binding experiments. Native factor VIII/von Willebrand factor exhibited negligible affinity while binding of the asialo derivative was comparable to that observed for asialo-alpha1-acid glycoprotein. Incubation of asialo-factor VIII/von Willebrand factor with Streptococcus pneumoniae beta-galactosidase removed only 62% of the galactose but abolished binding to the purified hepatic lectin. When the asialo derivative was incubated with purified beta-D-galactoside alpha2 leads to 6 sialyltransferase and CMP-[14C]NeuAc, only 61% of the galactose incorporated [14C]NeuAc. From the known specificites of these enzymes, it is concluded that galactose residues important in lectin binding are present in a terminal Gal/beta1 leads to 4GlcNAc sequence on asialo-factor VIII/von Willebrand factor. The relative ristocetin-induced platelet aggregating activity of native, asialo-, and agalacto-factor VIII/von Willebrand factor was 100:38:12, respectively, while procoagulant activity was 100:100:103.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 100492

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Partial deglycosylation of chloroplast coupling factor 1 (CF1) prevents the reconstitution of photophosphorylation.

Authors:  T E Maione; A T Jagendorf
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

2.  Lectin binding assays for in-process monitoring of sialylation in protein production.

Authors:  Weiduan Xu; Jianmin Chen; Glenn Yamasaki; John E Murphy; Baisong Mei
Journal:  Mol Biotechnol       Date:  2010-07       Impact factor: 2.695

Review 3.  Perioperative management of patients with von Willebrand's disease.

Authors:  C B Cameron; N Kobrinsky
Journal:  Can J Anaesth       Date:  1990-04       Impact factor: 5.063

4.  Carbohydrate of the factor VIII/von Willebrand factor in von Willebrand's disease.

Authors:  T S Zimmerman; R Voss; T S Edgington
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

5.  Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation.

Authors:  A B Federici; J H Elder; L De Marco; Z M Ruggeri; T S Zimmerman
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

6.  Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands.

Authors:  Lesley G Ellies; David Ditto; Gallia G Levy; Mark Wahrenbrock; David Ginsburg; Ajit Varki; Dzung T Le; Jamey D Marth
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-03       Impact factor: 11.205

7.  Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent.

Authors:  L De Marco; S S Shapiro
Journal:  J Clin Invest       Date:  1981-08       Impact factor: 14.808

8.  Glycogen storage disease type Ib: familial bleeding tendency.

Authors:  K Heyne; D Hosenfeld; W Grote; J Schaub
Journal:  Eur J Pediatr       Date:  1984-11       Impact factor: 3.183

9.  Comprehensive N- and O-glycosylation mapping of human coagulation factor V.

Authors:  Cheng Ma; Ding Liu; Dong Li; Junping Zhang; Xiao-Qian Xu; He Zhu; Xiu-Feng Wan; Carol H Miao; Barbara A Konkle; Philip Onigman; Weidong Xiao; Lei Li
Journal:  J Thromb Haemost       Date:  2020-06-14       Impact factor: 5.824

10.  Electron microscopy of human factor VIII/Von Willebrand glycoprotein: effect of reducing reagents on structure and function.

Authors:  K Ohmori; L J Fretto; R L Harrison; M E Switzer; H P Erickson; P A McKee
Journal:  J Cell Biol       Date:  1982-11       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.